Ethyl dirazepate
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
|
|
Identifiers | |
CAS Number | 23980-14-5 ![]() |
PubChem | CID 208941 |
ChemSpider | 181035 ![]() |
UNII | 74FAA305EW ![]() |
ChEMBL | CHEMBL2106231 ![]() |
Chemical data | |
Formula | C18H14Cl2N2O3 |
Molar mass | 377.221 |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]
See also[edit]
References[edit]
- ^ ZA Patent 6804601
- ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ^ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Retrieved 7 December 2009.
![]() |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |